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Abstract
Secreted Protein Acidic and Rich in Cysteine (SPARC) is one of the major non-structural proteins of the extracellular matrix
(ECM) in remodeling tissues. The functional significance of SPARC is emphasized by its origin in the first multicellular
organisms and its high degree of evolutionary conservation. Although SPARC has been shown to act as a critical modulator
of ECM remodeling with profound effects on tissue physiology and architecture, no plausible molecular mechanism of its
action has been proposed. In the present study, we demonstrate that SPARC mediates the disassembly and degradation of
ECM networks by functioning as a matricellular chaperone. While it has low affinity to its targets inside the cells where the
Ca
2+ concentrations are low, high extracellular concentrations of Ca
2+ activate binding to multiple ECM proteins, including
collagens. We demonstrated that in vitro, this leads to the inhibition of collagen I fibrillogenesis and disassembly of pre-
formed collagen I fibrils by SPARC at high Ca
2+ concentrations. In cell culture, exogenous SPARC was internalized by the
fibroblast cells in a time- and concentration-dependent manner. Pulse-chase assay further revealed that internalized SPARC
is quickly released outside the cell, demonstrating that SPARC shuttles between the cell and ECM. Fluorescently labeled
collagen I, fibronectin, vitronectin, and laminin were co-internalized with SPARC by fibroblasts, and semi-quantitative
Western blot showed that SPARC mediates internalization of collagen I. Using a novel 3-dimentional model of fluorescent
ECM networks pre-deposited by live fibroblasts, we demonstrated that degradation of ECM depends on the chaperone
activity of SPARC. These results indicate that SPARC may represent a new class of scavenger chaperones, which mediate
ECM degradation, remodeling and repair by disassembling ECM networks and shuttling ECM proteins into the cell. Further
understanding of this mechanism may provide insight into the pathogenesis of matrix-associated disorders and lead to the
novel treatment strategies.
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Introduction
SPARC is a matricellular protein with multiple functions. It
regulates the assembly and organization of the extracellular matrix
(ECM) [1], modulates multiple intracellular signaling pathways
and affects cell migration, proliferation and differentiation [2].
SPARC expression is tightly regulated to confine its activity to the
sites of matrix remodeling. It binds multiple structural and soluble
ECM proteins in a Ca
2+-dependent manner, including collagens
[3,4,5,6], vitronectin [7], fragments of fibrinogen [8], thrombos-
pondin-1 [9,10], vascular endothelial growth factor (VEGF) [11]
and platelet-derived growth factor (PDGF) [12]. Although the
functional significance of this binding is unclear, it has been
suggested that SPARC may function as an extracellular chaperone
[13]. SPARC is a secreted protein that is induced by heat shock
and other forms of stress [14,15], and its secondary structure
remains stable up to 50uC [16]. In a standard assay for chaperone
activity, SPARC prevents thermal aggregation of alcohol dehy-
drogenase (ADH) [16]. It has also been demonstrated to function
as a collagen chaperone by affecting the formation of fibrils in vitro
[17].
SPARC is a major non-structural protein in bone, where
extensive matrix remodeling is required to maintain its composi-
tion. During bone remodeling, osteoclasts mediate scavenging of
collagen through an endosomal/lysosomal pathway with subse-
quent degradation or removal into the bloodstream by transcytosis
[18]. After limited proteolysis by cathepsin K, SPARC is also
internalized by osteoclasts and their precursors, mononuclear cells
[19]. Internalization of SPARC has been described in activated
macrophages and sinusoidal endothelial cells [20] and embryonic
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6chicken cells [21]. SPARC-like peptides are internalized by
integrin a5b1 complex in adipose stem cells [22]. We previously
demonstrated that mouse NIH/3T3 fibroblasts internalize exog-
enously added SPARC [23].
So far, no functional model which integrates binding to matrix
proteins, chaperone activity, internalization, and other properties
of SPARC has been proposed. In this study, we demonstrated that
SPARC acts as a scavenger chaperone, which mediates degrada-
tion of ECM. Binding of SPARC to the matrix proteins is
regulated by a Ca
2+-switch, and leads to the disassembly of ECM
networks. We showed that SPARC shuttles between the intra- and
extracellular space and directs internalization of ECM proteins.
Further, using fluorescent ECM networks deposited by live cells,
we demonstrated that this chaperone activity is required for matrix
degradation.
Materials and Methods
Animals, cell lines and reagents
SPARC-null mice were obtained from Dr. Helene Sage
(Benaroya Research Institute, Seatle, WA) and bred into
129X1/SVJ strain for 3 generations. Animals were kept in a
pathogen-free facility and treated according to the NIH guidelines
for animal care and use. Protocols were approved by the Animal
Care and Use Committee at The University of Chicago, approval
71829. To isolate primary fibroblasts from the skin of SPARC-null
and wild type mice, tissues were rinsed with sterile phosphate
buffered saline (PBS), sectioned, and placed in DMEM media (Life
Technologies Inc, Grand Island, NY) supplemented with 10%
fetal bovine serum (FBS, Life Technologies). Fibroblasts were
allowed to spread at 37uCi n5 %C O 2, tissue sections were
removed and cell morphology was confirmed. All primary cultures
were maintained for no longer than 6 passages. Primary human
skin fibroblasts BJ, NIH/3T3 mouse fibroblasts, and HEK293
cells were purchased from the American Type Culture Collection
(ATCC, Manassas, VA) and cultured at 5% CO2 in DMEM with
10% FBS. Recombinant histidine-tagged SPARC was produced in
HEK293 cells and purified as described [24].
Collagen fibril assays
For collagen fibril formation [25], 33 ml of acidic solution of
bovine collagen I (Vitrogen, Palo Alto, CA) was neutralized and
diluted to 1 mg/ml with 66 ml of PBS, containing indicated
amounts of SPARC or BSA (Sigma, St. Louis, MO) at 4uC in a 96-
well plate. Fibrillogenesis was started by placing the samples in a
Synergy 2 plate reader (BioTek, Winooski, VT) pre-warmed to
37uC. Turbidity was monitored by measuring absorbance at
360 nm every 2 min for 2 h at 37uC. For fibril degradation,
collagen gels were pre-formed in 96-well plates as above. Indicated
amounts of SPARC or BSA were added to the collagen gels in
30 ml of PBS at room temperature. Where indicated, Ca
2+ or
EDTA was added to the protein solutions to achieve 1 mM final
concentrations. Fibril degradation was started by placing samples
in a plate reader pre-warmed to 47uC and monitored by recording
the turbidity at 360 nm every 2 min for 100 min. All data were
analyzed by subtracting blank readings and calculating the
average of triplicate measurements in at least three experiments.
Statistical significance was determined with single-factor ANOVA.
Immunofluorescence
Cultured cells grown on coverslips were fixed with 1%
paraformaldehyde at room temperature for 20 min, washed twice
with PBS and permeabilized with 70% ethanol at 220uC for at
least 20 min. Non-specific immunostaining was blocked by pre-
incubation in PBS with 5% donkey serum. Target protein
expression was detected by incubation in blocking solution for
1 h at room temperature with goat anti-SPARC antibody (R&D,
Minneapolis, MN) at 1:200 dilution, and mouse anti-dynamin
antibody (Merck, Darmstadt, Germany) at 1:200 dilution.
Immunocomplexes were visualized with FITC-labeled anti-goat
and Texas Red-labeled anti-mouse secondary antibodies (Jackson
Immunoresearch Labs, West Grove, PA). Slides were mounted in
ProLong Gold (Invitrogen, Carlsbad, CA) and examined under a
DB IRB inverted fluorescent microscope (Leica, Heidelberg,
Germany).
Fluorescent matrix assays
Green fluorescent tags were added to recombinant SPARC or
collagen I using Alexa Fluor 488 Microscale Labeling Kit (AF488,
Invitrogen, Carlsbad, CA), and red fluorescent tags were added to
collagen I, fibronectin (Millipore, Billerica, MA), laminin (Chemi-
con, Temecula, CA), and vitronectin (Promega, Madison, WI)
with Alexa Fluor 594 Microscale Labeling Kit (AF594, Invitrogen,
Carlsbad, CA) using manufacturer’s protocol. In most experi-
ments, collagen I was denatured by boiling for 5 min prior to
labeling. This treatment prevents formation of fibrils in the
labeling reaction and significantly enhances its efficiency. Boiled
collagen was functionally indistinguishable from native collagen in
any of the experiments in this study.
For the treatment with soluble labeled ECM components and
SPARC, fibroblasts were cultured overnight on glass coverslips in
24-well plates. Fluorescently labeled proteins were added to the
fibroblasts at 1 mg/ml in serum-free media as detailed in the
Results section for each particular experiment. After the
treatment, cells were fixed in 1% paraformaldehyde for 20 min
at room temperature, rinsed twice with PBS and mounted in
ProLong Gold. Distribution of labeled proteins was examined
under a Leica DB IRB fluorescent microscope.
Three-dimensional matrixes were pre-deposited using published
methodology [26], with added fluorescent proteins to allow
visualization. Mouse NIH/3T3 fibroblasts were cultured on
Matrigel (Discovery Labware, Bedford, MA)-coated coverslips in
the presence of 5 mg/ml of AF488-labeled collagen I alone or in
combination with 5 mg/ml of AF-594-labeled fibronectin in
complete media. When dense fluorescent networks were visible
by fluorescent microscopy, cells were removed by treatment with
20 mM NH4OH, coverslips were rinsed twice with PBS, and
denuded matrixes were stored in PBS at 4uC for up to 2 weeks. To
assess matrix remodeling and degradation, SPARC-null and wild
type fibroblasts were cultured on fluorescent matrixes for the
indicated periods, fixed and mounted as above. Matrixes were
examined under a Leica DB IRB microscope and photographed.
The matrix area was quantified at 6600 magnification in at least
quadruplicate fields in three independent experiments using
ImagePro software. Statistical significance was determined with
Student’s t-test for individual time points.
Internalization and pulse-chase assays
Primary SPARC-null fibroblasts were cultured overnight in a
24-well plate in complete media, rinsed with PBS and treated with
proteins in serum-free media. To assess the internalization of
SPARC, cells were treated with 5 mg/ml or 1 mg/ml of
recombinant SPARC. After indicated periods, cells were rinsed
with PBS, lysates were prepared and intracellular proteins detected
by Western blot analysis as described [27] using anti-SPARC
antibody at 1:1000 dilution.
To study the effect of SPARC on the internalization of collagen,
cells were treated with 5 mg/ml of SPARC and 5 mg/ml of AF488-
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periods, cells were rinsed with PBS and lysed with 2% sodium
deoxycholate in PBS. Intracellular proteins were detected by
Western blot analysis as above with anti-AF488 antibody
(Invitrogen, Carlsbad, CA) at 1:5000 dilution.
For the pulse-chase assay, SPARC-null fibroblasts were treated
with 1 mg/ml of recombinant SPARC for 2 h in serum-free
DMEM. After the pulse, exogenous SPARC was removed by
rinsing with PBS and replacing the media. The amount of
internalized SPARC in cell lysates and excreted SPARC in the
media was determined by Western blot as above. All experiments
were repeated at least three times with consistent results. For
quantitative analysis, densities in individual experiments were
normalized and represented as an average of three experiments
6SD. Statistical significance for individual time points was
determined with Student’s t-test.
Results
Disassembly of collagen networks by SPARC is regulated
by a Ca
2+-switch
SPARC is a secreted stress-induced protein with chaperone
properties [14,15]. Chaperones of the heat-shock family assist in
the folding and repair of cytoplasmic proteins or facilitate their
unfolding and degradation [28]. Because folding requires energy
and ATP is lacking outside the cell, we hypothesized that SPARC
mediates the unfolding of target proteins. To test this hypothesis,
the effect of SPARC on the formation of collagen fibrils [25] was
examined. As shown in figure 1a, the addition of SPARC to
collagen monomers at 1:1 molar ratio inhibited the formation of
collagen fibrils by 99.7%. The effect was concentration-dependent,
and at a 1:2 or 1:3 ratio per collagen monomer, SPARC inhibited
formation of fibrils by 91.8% and 44.9% respectively, demon-
strating that SPARC prevents formation of collagen fibrils.
To directly test the effect of SPARC on the disassembly of
collagen networks, pre-formed collagen fibrils were incubated at
47uC, a temperature that induces fibril degradation and a loss of
opacity. The addition of SPARC at 1:1 ratio per collagen
monomer caused complete loss of opacity in 100 min, a nearly a
100% increase in fibril degradation compared to control (figure
1b). These results indicate that SPARC mediates the disassembly
of collagen networks.
Ca
2+ affinity of SPARC EF-hand domains [29] suggests that
they may be able to function as a sensor, discriminating between
low intracellular and high extracellular concentrations of Ca
2+.
We have tested if the ability of SPARC to disassemble collagen
fibrils requires high concentrations of Ca
2+. As shown in figure 1b,
this activity was completely lost in the presence of EDTA,
demonstrating that Ca
2+ binding to the EF-hand domains
regulates chaperone activity of SPARC, switching between
inactive intracellular and active extracellular conformations.
SPARC shuttles between extra- and intracellular
compartments
The ability of SPARC to bind multiple extracellular proteins [2]
suggests that after its secretion and activation by Ca
2+, the
majority of SPARC is bound to various ECM proteins.
Internalization of secreted SPARC by different cell types has
been previously described [19,20,21,23]. We confirmed that
exogenously added SPARC is actively internalized by all types
of fibroblasts, including mouse NIH/3T3 fibroblasts, human
primary skin fibroblasts BJ and fibroblasts isolated from SPARC-
null mice (data not shown). In mouse NIH/3T3 fibroblasts,
intracellular SPARC-positive vesicles did not undergo visible
degradation for as long as the cells remained alive in serum-free
media, and did not appear to co-localize with dynamin, the
marker of caveolae and clathrin-coated vesicles (figure 2a).
SPARC added to the media can be detected by Western blot
inside primary fibroblasts from SPARC-null mice as early as in
1 min. Intracellular SPARC levels increased up to 1–2 hours after
the start of treatment and remained relatively constant afterwards
(figure 2b and c). After adding exogenous protein to the SPARC-
null fibroblasts in a 2 h pulse, internalized SPARC can be detected
in the fresh media 1 min after the pulse. The amount of released
protein stably increased over a period of 24 h (figure 2d and e),
which correlated with a corresponding decrease in the cytoplasmic
SPARC.
Together, these experiments demonstrate that secreted SPARC
is rapidly internalized by the fibroblasts, and rapidly released back
to the extracellular space, indicating that SPARC shuttles between
the extracellular matrix and the cytoplasm. It is therefore a
matricellular chaperone, in full accordance with the meaning of
term ‘‘matricellular’’ [30].
SPARC does not affect deposition of ECM networks
To study the impact of SPARC on the formation of ECM
networks by live cells, SPARC was conjugated with green
fluorescent dye AF488, and ECM proteins were conjugated with
red fluorescent dye AF594. When added to the cultured primary
fibroblasts isolated from SPARC-null mice, red fluorescent
collagen was deposited into extracellular fibrillar networks in a
pattern consistent with its normal function. In a moving fibroblast,
the majority of collagen was deposited in the fibrils at the trailing
edge, while labeled SPARC was actively internalized at the leading
edge. SPARC also bound ECM components deposited by the
fibroblast along the moving path, visible as green tracks left behind
the cell (Figure 3a). Quiescent cells also deposited labeled collagen
into extracellular fibrillar networks. In addition, significant
Figure 1. SPARC mediates disassembly of ECM networks. (A)
Collagen fibril formation at 37uC was almost completely prevented by
SPARC. Density of collagen networks measured by opalescence at 2 h
was decreased by 99.767.2% (F=249) for 1:1 and by 91.868.2%
(F=224) for 1:2 molar ratio of SPARC to collagen monomer respectively,
as compared with PBS control. At 1:3 ratio, SPARC prevented formation
of collagen fibrils by 44.9614.2% (F=46). BSA at the same ratios did not
cause statistically significant change in fibril formation (F,3.92). (B)
Degradation of pre-formed collagen fibrils at 47uC doubled when
SPARC was addedat 1:1 molar ratio to collagen monomer with the
complete loss of opacityin 100 min. Collagen fibril degradation was
only enhanced by SPARC in 1 mM Ca
2+ (F=60), and was completely
abolished in 1 mM EDTA (F,3.90). The same amount of BSA or PBS
without proteins did not affect degradation of collagen fibrils neither in
Ca
2+, nor EDTA (F,3.90).
doi:10.1371/journal.pone.0023880.g001
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that collagen is actively internalized. Labeled SPARC was also
internalized and overlay of red and green colors in figure 3b shows
that both proteins are contained in the same vesicles. Labeled with
red AF594 fibronectin, laminin and vitronectin were also
deposited into extracellular networks by primary fibroblasts and
co-internalized with SPARC in the same vesicles.
The dynamics of the assembly of collagen networks suggested
that their formation occurs exclusively outside of the cell and does
not require intracellular trafficking of collagen or the presence of
SPARC (figure 4a and b). First extracellular fibrils form as quickly
as 10 min after the addition of fluorescent collagen and the
networks continue to expand until several hours after the
treatment (figure 4a). Internalization of collagen starts only when
the first fibrils are formed, and it is accompanied by the
degradation of the networks, which becomes apparent at 24 h
after the treatment.
SPARC promotes internalization of collagen
Binding SPARC to the ECM proteins outside the cell and the
co-localization of SPARC and ECM proteins inside the cell
suggests that SPARC directs the internalization of its targets. To
test this hypothesis, SPARC-null fibroblasts were treated with
collagen alone and collagen in combination with SPARC.
Exogenously added collagen was labeled with AF488 to distinguish
it from endogenously produced collagen. Using anti-AF488
antibody, we showed that internalization of collagen occurs
immediately after the treatment and continues to increase for 2–
4 h (figure 4b and c). Statistically significant increase of collagen
internalization by SPARC was first observed in 30 min after the
treatment (p=0.005), at the same time when robust extracellular
networks are formed (figure 4a). In 2–4 h after the treatment, the
amount of internalized collagen was increased by SPARC ,3 fold.
Together with previous observations, this indicates that SPARC
mediates the degradation of pre-formed ECM networks and
directs internalization of their components.
SPARC promotes degradation of ECM networks
To directly test the role of SPARC in the degradation of ECM
networks, we modified an experimental model of 3-dimentional
matrixes in vitro [26] by adding fluorescently labeled ECM
proteins. Figure 5a demonstrates that cultured NIH/3T3
fibroblasts form extensive 3-dimentional ECM networks, which
incorporate fluorescent collagen, and remain intact after removal
of the cells.
To study ECM degradation, the networks were formed with
green AF488-labeled collagen and red AF594-labeled fibronectin.
Both proteins showed almost complete co-localization, the
networks remained intact after cell removal and were stable in
tissue culture conditions for at least 48 h (figure 5b). When
SPARC-null fibroblasts were grown on these pre-deposited
fluorescent matrices, re-arrangement of fibrils was detected shortly
Figure 2. Internalization of SPARC by fibroblastcells. (A) After treatment with exogenous SPARC for indicated periods, bright intracellular
vesicles containing internalized SPARC were detected by immunofluorescence in the cytoplasm of mouse NIH/3T3 fibroblasts. Exposure time was
chosen to minimize interferenceof endogenously expressed SPARC, which can be detected in untreated cells. Lack of co-localization with the marker
of caveolae and clathrin-coatedvesicles, dynamin, was apparent at 5 and 15 min time points. (B) Representative Western blot and (C) semi-
quantitative analysisof SPARC in the cytoplasm of primary fibroblasts, isolated from SPARC-nullmice. After addition of 5 mg/ml of SPARC tothe culture
media, it was detected in cell lysates in 1 min with increasing accumulation until 1–2 hours. Treatment with 1 mg/ml of SPARC resulted in weaker
internalization which followed the same dynamic. (D) Representative Western blot and (E) semi-quantitative analysis of SPARC turnover in the pulse-
chase assay. SPARC-null fibroblasts were treated with 5 mg/ml of SPARC added to themedia. The amount of SPARC in the media and internalized
bythe fibroblasts at the end of pulse treatment is shown in the first lane.After SPARC was removed from the media, both media and cell lysates were
collected at the indicated time points. Western blot analysis showed rapid, time-dependent release of SPARC from the fibroblasts, accompanied bya
decrease in the amount of intracellular SPARC.
doi:10.1371/journal.pone.0023880.g002
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the cells, merged and increased in thickness. Although some
degradation of fibrils occurred after 24–48 h, the loss of
fluorescence by quantitative image analysis was not statistically
significant. In contrast, when SPARC-positive wild type fibroblasts
were grown on these matrices, the re-arrangement of fibrillar
networks was accompanied by intense degradation. The loss of
fluorescence was statistically significant at 6 h and almost complete
at 24–48 h, demonstrating that SPARC mediates degradation of
ECM networks, acting as a scavenger chaperone.
Discussion
Recent discoveries started to change the traditional perception
of ECM as an inert support for live cells. Early embryonic lethality
in knockout animals proved that matrix proteins are essential for
the development and architecture of tissues [31]. The discovery of
integrins and cell-matrix signaling demonstrated that ECM
controls the most critical aspects of cell physiology and maintains
the ‘‘integrity’’ of the tissue [32]. Advances in stem cell research
uncovered significant potential for regeneration and repair of
abnormalities in the cellular component, further emphasizing the
importance of extracellular abnormalities. Matrix abnormalities
have already been shown to cause a number of chronic and acute
diseases, age-associated and genetic disorders [33], and to support
cancer progression [34]. Understanding the mechanism of matrix
remodeling and repair is essential for disease prevention and the
development of new therapies.
SPARC is a non-structural ECM protein associated with matrix
remodeling, which appears in the first multicellular organisms. It
remains highly conserved during evolution, suggesting the
importance of its function. In higher metazoans, this function
has been further multiplied in a number of structurally and
functionally related proteins [35,36,37]. Lethal in primitive
organisms, abrogation of SPARC has progressively milder effects
in higher animals due to this functional compensation [1]. In more
than 30 years since its discovery [38], SPARC has been shown to
act as an essential modulator of cell-matrix interactions, which
affects cell attachment, migration, proliferation, differentiation,
signaling, matrix deposition and degradation [2]. Nevertheless, the
molecular mechanism responsible for these functions of SPARC
remains unclear.
In this study we demonstrate that SPARC functions as an
extracellular chaperone that mediates the disassembly and
degradation of ECM networks. We propose that at high
concentrations of Ca
2+ in the extracellular space, SPARC binds
multiple ECM targets, promotes the disassembly of solid networks,
and directs the internalization of their components. At low
intracellular concentrations of Ca
2+ it has to release its target, and
free SPARC is recycled outside the cell, serving as a shuttle for
scavenging various structural and soluble extracellular proteins.
Thus, SPARC may represent a new functional class of scavenger
chaperones, necessary for the dynamic regulation of ECM
composition and the repair of matrix abnormalities.
The chaperone activity of SPARC may be regulated by several
factors. Binding SPARC to its known soluble and structural ECM
targets is Ca
2+-dependent [3,4,5,7,10,35,39]. The C-terminal
extracellular calcium-binding domain of SPARC contains a
canonical pair of EF-hand motifs that cooperatively bind Ca
2+
with macroscopic Kd of 490 nM and 57 nM, and half-saturation
at a free Ca
2+ concentration of 170 nM [29]. These highly
conserved helix-loop-helix Ca
2+-binding motifs are usually found
in cytosolic proteins of the Ca
2+ second messenger system, where
they distinguish between intracellular Ca
2+ concentrations of
,0.1 mM in resting, and ,10 mM in activated cells. The
regulatory role of EF-hand motifs in secreted proteins is unclear,
because extracellular concentrations of Ca
2+ remain at a constant
high level of ,1.2 mM [29].
High extracellular concentrations of Ca
2+ are sufficient to bind
the EF-hand motifs in SPARC and to induce conformational
changes which activate binding to collagen with high affinity [40].
Cytosolic Ca
2+ concentrations in the resting cell are too low to
Figure 3. Co-internalization of SPARC and ECM proteins in fibroblasts. (A) Primary mouseSPARC-null fibroblasts were attached to glass
coverslips overnight and treated with red AF594-labeled collagen and green AF488-labeled SPARC. After 1 h of treatment, strong fibrillar
collagennetworks were deposited at the trailing edge of a moving fibroblast (purple arrow). Fluorescent SPARC bound ECM tracks, deposited along
the movement path (blue arrows) and was internalized at the leading edge of the fibroblast (white arrow). (B) SPARC-null fibroblasts were plated and
treated with green AF488-labeled SPARC and red AF594-labeled ECM proteins as above. Allmatrix proteins were deposited into apparently normal
extracellular networks and internalized by the cells. Strong co-localizationof all internalized ECM proteins with SPARC is evident by the yellow overlap
of the two colors.
doi:10.1371/journal.pone.0023880.g003
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2+ concentrations are higher
in activated cell or in early endosomes [41,42], they are insufficient
to induce Ca
2+-dependent conformational transition [43], and
SPARC remains in an inactive state with low affinity to its ligands
[35]. Thus, the chaperone activity of SPARC may be controlled
by a Ca
2+-switch between a high-affinity ligand-bound state
outside and a low-affinity ligand-free state inside the cell.
Cleavage by extracellular proteases increases SPARC affinity to
collagens up to 20-fold [5,44] and may be another important
switch in the regulation of its activity. Concentrations of SPARC
in tissues are difficult to measure, but micromolar Kd for most of
the collagens indicate that there may be not enough SPARC for
binding in normal conditions. Higher levels of expression and/or
activation by extracellular proteases at the sites of tissue
remodeling may be necessary to increase binding and to promote
scavenging of a wider range of targets.
Knowledge of the range of SPARC targets and affinity of their
binding may be important for other aspects of tissue physiology.
Although binding of SPARC to serum albumin has not been
studied in detail since its discovery [45], this property of SPARC
has been ascribed to the mechanism of drug delivery by
nanoparticle albumin-bound drugs [46]. It will be important to
clarify, whether internalization of SPARC is mediated by the
albumin receptor gp60, which has already been shown to bind
SPARC on endothelial cells [47], and if the chaperone function of
SPARC is required for albumin transcytosis across the endothelial
cell layer in normal blood vessels [48], which is stimulated by
SPARC [49].
In an apparent contradiction, the phenotype of SPARC
knockout mice [50,51] suggests abnormality in matrix deposition
and maturation rather than impaired matrix degradation. These
animals develop early-onset cataracts [50,51], profound age-
progressive osteopenia [52], abnormalities in collagen deposition
in fragile skin [53], and enlarged adipose tissue [54]. Despite
significant acceleration of wound healing [55], scars are abnormal
and collagen deposition is impaired in SPARC-null animals with
cardiac infarcts, causing increased incidence of cardiac rupture
and 4-times higher mortality [56].
The issue can be resolved if proper scavenging is necessary to
remove abnormalities during matrix deposition and to prevent
premature termination of growing ECM networks. Indeed,
unusually high rates of matrix degradation indicate that it is
essential for normal ECM deposition and maturation. Most of
newly synthesized collagen is immediately degraded, especially in
tissues with high functional requirements. This process increases
with age, reaching about a 90% ratio of degradation to synthesis in
heart and muscle tissues [57]. A lack of repair may be evident in
the eye lens of SPARC-null mice, where accumulated abnormal-
ities lead to a loss of transparency. In transgenic animals, SPARC
has also been demonstrated to associate with other age- and
Figure 4. Effect of SPARC on collagen turnover. (A) SPARC-null primary mouse fibroblasts were treated with green AF488-labeled SPARC (left
panel), red AF594-labeled collagen (right panel) or their combination (middle panels). Formation of cytoplasmic vesicles containing internalized
SPARC follows the same dynamic, as determined by Western blot analysis. Collagenwas deposited into fibrillar extracellular networks in 2–4 hafter
the treatment. When significant uptake of collagen was observed, it was internalized in SPARC-positive vesicles. (B) Representative Western blot and
(C) semi-quantitative analysis of exogenously added AF488-labeled collagen in the cytoplasm of SPARC-null fibroblasts. Treatment with SPARC led to
a statistically significant (p,0.05) 2–3 times increase in collagen internalization at 30 min–48 h. Substantial degradation of collagen was also be
observed in 24 and 48 h after the treatment.
doi:10.1371/journal.pone.0023880.g004
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crease in myocardial stiffness [59].
Essentially two mechanisms of collagen degradation are
currently recognized. In the extracellular pathway, matrix is
cleaved by secreted matrix metalloproteinases and cathepsin [60].
In the intracellular pathway, collagen receptors a2b1-integrin or
urokinase plasminogen activator receptor-associated protein
(uPARP/endo180) mediate phagocytosis and lysosomal degrada-
tion of collagen in fibroblast cells [61,62]. Whether SPARC is
capable of connecting extra- and intracellular pathways by
clearing proteolysed ECM debris, should be addressed in the
future. Further studies of dynamic interactions between cells and
their extracellular environment will also be required to validate the
importance of scavenger chaperone(s) in normal and pathologic
physiology. It is nevertheless evident that matrix remodeling and
repair is indispensable for the normal function of tissues and
organs. A further understanding of SPARC’s role as a chaperone
for ECM proteins will provide insight into the pathogenesis of
matrix-associated disorders, and may lead to the development of
novel treatment strategies.
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